Literature DB >> 8647219

Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism.

A A Gaspari1, G D Sempowski, P Chess, J Gish, R P Phipps.   

Abstract

Although the expression and function of CD40 on B lymphocytes has been well studied, the significance of CD40 on non-lymphoid cells such as keratinocytes (KC) is not as well characterized. We demonstrate in this report that CD40 is expressed by virtually all human KC, and that it functions as an important signaling molecule. Flow cytometry of undifferentiated and terminally differentiated KC indicated that both cell types expressed CD40, as determined by binding to monoclonal antibodies and a recombinant CD40 ligand fusion protein; interferon-gamma (IFN-gamma) treatment of KC increased CD40 expression. Cultured KC also expressed 1.5-kb CD40 transcripts. Activation of KC cell surface CD40 using the monoclonal antibody G28.5 resulted in the rapid generation of a 50-kDa tyrosine phosphorylated polypeptide, as well as a dose-dependent increase in the secretion of interleukin-6, a cytokine that has been linked to KC proliferation. KC also co-stimulated a significant T lymphocyte proliferative response to the mitogen phytohemagglutinin that was CD40 dependent. These data indicate that KC constitutively express a low level of functional CD40 and regulate their expression in response to IFN-gamma. These data support the concept that KC, via their expression of CD40, have the capacity to amplify inflammation in the skin by interacting with CD40 ligand-bearing T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647219     DOI: 10.1002/eji.1830260629

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.

Authors:  R S Smith; T J Smith; T M Blieden; R P Phipps
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

3.  CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury.

Authors:  Constance Barazzone Argiroffo; Yves R Donati; Julien Boccard; Anne F Rochat; Christian Vesin; Chen-Da Kan; Pierre-François Piguet
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts.

Authors:  L Koumas; A E King; H O Critchley; R W Kelly; R P Phipps
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

5.  CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.

Authors:  N J Gallagher; A G Eliopoulos; A Agathangelo; J Oates; J Crocker; L S Young
Journal:  Mol Pathol       Date:  2002-04

6.  Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome.

Authors:  A Adawi; Y Zhang; R Baggs; J Finkelstein; R P Phipps
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 7.  The platelet as an immune cell-CD40 ligand and transfusion immunomodulation.

Authors:  Neil Blumberg; Sherry L Spinelli; Charles W Francis; Mark B Taubman; Richard P Phipps
Journal:  Immunol Res       Date:  2009-01-29       Impact factor: 2.829

8.  Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.

Authors:  J R Abrams; S L Kelley; E Hayes; T Kikuchi; M J Brown; S Kang; M G Lebwohl; C A Guzzo; B V Jegasothy; P S Linsley; J G Krueger
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

9.  CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV.

Authors:  Bart Tummers; Renske Goedemans; Veena Jha; Craig Meyers; Cornelis J M Melief; Sjoerd H van der Burg; Judith M Boer
Journal:  J Invest Dermatol       Date:  2014-06-19       Impact factor: 8.551

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.